AKT1 and thymus lymphoma: PTEN is a major negative regulator of the PI3K/Akt signaling pathway and we thus hypothesized that increased PTEN protein level in developing thymic lymphomas inhibits Akt signaling to hinder the growth of these tumors as observed.